Cointime

Download App
iOS & Android

CRISPR Therapeutics

company
Exit Type
IPO
Exit Date
Oct 19, 2016

Exit parties in this round

Partner Fund Round Return Amount Return Multiplier
Bayer Global Investments Series B Detail
Versant Ventures Series C Detail